VHA Purchase Agreements With 15 Device Firms Will Save $167 Annually
This article was originally published in The Gray Sheet
Fifteen device manufacturers have signed agreements with VHA worth an estimated $760 mil. in annual committed member purchases over the next three years. The agreements, dubbed the Opportunity program, cover 25 selected device categories in cardiac catheterization, orthopedics and anesthesiology. The group purchasing organization estimates that the agreements will save its member organizations $167 mil. while improving participating manufacturers' market shares.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.